| Author | dc.contributor.author | Quera Pino, Rodrigo | es_CL |
| Author | dc.contributor.author | Quigley, Eamonn M. M. | es_CL |
| Author | dc.contributor.author | Madrid Silva, Ana | |
| Admission date | dc.date.accessioned | 2009-05-18T15:51:08Z | |
| Available date | dc.date.available | 2009-05-18T15:51:08Z | |
| Publication date | dc.date.issued | 2005-11 | |
| Cita de ítem | dc.identifier.citation | v.133 n.11, p.1361-1370, nov.,2005, Revista Médica de Chile | en |
| Identifier | dc.identifier.issn | 0034-9887 versión impresa | |
| Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/127862 | |
| Abstract | dc.description.abstract | Small intestinal bacterial overgrowth (SIBO) is characterized by
nutrient malabsorption, associated with an excessive number of bacteria in the proximal small
intestine. Unfortunately, the diagnosis of bacterial overgrowth presents several difficulties and
limitations, and as yet there is not a widespread agreement on the best diagnostic test. SIBO
occurs when there are alterations in intestinal anatomy, gastrointestinal motility, or a lack of
gastric acid secretion. The true association between SIBO and irritable bowel syndrome and
celiac disease remains uncertain. The treatment usually consists in the eradication of bacterial
overgrowth with repeated courses of antimicrobials, nutritional support and when it is possible,
the correction of underlying predisposing conditions. | en |
| Lenguage | dc.language.iso | es | en |
| Publisher | dc.publisher | Sociedad Médica de Santiago | en |
| Keywords | dc.subject | Anti-bacterial agents | en |
| Título | dc.title | Sobrecrecimiento bacteriano intestinal | en |
| Document type | dc.type | Artículo de revista | |
